NCT03127787View on ClinicalTrials.gov

Clinical Performance Evaluation of DxN CMV Assay

TerminatedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
Cytomegalovirus
Interventions
DIAGNOSTIC_TEST

CMV Assay

Molecular diagnostic test to detect CMV

Trial Locations (4)

Unknown

UCLA, Los Angeles

NWU, Chicago

IU, Indianapolis

Mayo, Rochester

Sponsors
All Listed Sponsors
lead

Beckman Coulter, Inc.

INDUSTRY